share_log

東曜藥業-B:函件一及回條 – 選擇公司通訊的收取方式

TOT BIOPHARM-B: FIRST LETTER AND REPLY FORM - ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS

香港交易所 ·  Dec 28, 2023 05:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more